Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pelargo is an over-the-counter (OTC) herbal medicine developed by Pascual Laboratories for the treatment of common cold symptoms, including nasal congestion, runny nose, sneezing, and headache. The active ingredient is a standardized extract of the root of *Pelargonium sidoides* DC., a medicinal plant native to South Africa. Pelargo functions as a natural secretolytic and decongestant, working to loosen respiratory mucus and facilitate its clearance, thereby shortening the duration and reducing the severity of cold symptoms. Clinical evidence supports its efficacy, with significant improvements typically observed within five days of administration. It is marketed as a natural health product and is available in a 20mg tablet form.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pelargo.